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Fear memory formation critically relies on the function of
the lateral amygdala (LA) and changes in synaptic trans-
mission of its sensory inputs. There is evidence that sign-
aling through NO/cGMP in the amygdala contributes to
these processes [1-3]. The cGMP-dependent protein
kinases (cGK) type I and II serve as universal effectors of
the NO/cGMP signaling cascade. Recently, we established
a functional role of cGKI for synaptic plasticity and fear
memory consolidation in the amygdala. First, we demon-
strated that the cGKIβ isoform is highly expressed in the
LA. Furthermore, we showed that cGKI-deficient mice
revealed deficits in amygdala-dependent fear memory
consolidation. In contrast, short-term memory and hip-
pocampus-dependent memory was intact in these mice.
In line with the behavioral phenotype of impaired audi-
tory long-term memory, we found reduced long-term
potentiation (LTP) in the LA of cGKI-deficient mice,
which is considered as a cellular mechanism for learning
induced synaptic plasticity. Unlike cGKI-deficient mice,
cGKII-knockout mice lack these phenotypes. These results
clearly suggest a crucial role of cGKI for consolidation of
amygdala-dependent fear memory, a process by which
newly learned information is stabilized into long-term
memory (LTM). It is a well known fact that memory con-
solidation strictly depends on transcriptional and transla-
tional processes which is also proved essential for
amygdala-dependent fear memory consolidation [4,5]. A
functional link between cGKI activity and gene transcrip-
tion could already be demonstrated in vitro [6]. The
upcoming question is if cGKI-induced transcription also
takes place in amygdala neurons recruited during memory
formation. Preliminary data indicate a role for cGKI in
cAMP-response element binding protein (CREB) signal-
ing in the LA, a prominent transcription factor involved in
learning and memory.
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